Aradigm

United States
Ellsworth, Wisconsin, United States, 94545

Company profile

Aradigm company profile

Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of a portfolio of drugs delivered by inhalation for the treatment of severe respiratory diseases by pulmonologists. The Company has product candidates addressing the treatment of bronchiectasis, cystic fibrosis, inhalation tularemia and anthrax infections, and smoking cessation.

Business identity

Contact email
[email protected]
Phone number
+1 510 265-9000
Operating status
Closed
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0+
Founded
1991-01-01, Year

Headquarters

Postal code
94545
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
3
Total equity funding
$4.1M
Last funding
Post IPO Debt / $23M / 2016-05-03
Last equity funding
Post IPO Equity / $4.1M
Investors
4
Founders
1
Articles
23
Closed on
2020-06-30
Exited on
1996-06-20

Founders and investors

Founders

Reid Rubsamen

Investors

Camden PartnersCastle Creek PartnersDomain AssociatesNew Enterprise Associates